Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder
Efficacy and Tolerability of Magnetic Seizure Therapy (MST) as an Alternative to Electroconvulsive Therapy (ECT) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder
Sponsor: Centre for Addiction and Mental Health
Listed as NCT01596608, this NA trial focuses on Depressive Disorder and Obsessive-Compulsive Disorder and remains completed. Sponsored by Centre for Addiction and Mental Health, it has been updated 11 times since 2012, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jul 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2020 — Jul 2020 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Jan 2020 — Mar 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Jan 2020 [monthly]
Recruiting NA
-
Dec 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre for Addiction and Mental Health
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .